Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1933 1
1952 1
1954 1
1962 1
1966 2
1967 3
1968 1
1970 7
1971 8
1972 8
1973 3
1974 7
1975 21
1976 33
1977 22
1978 23
1979 35
1980 50
1981 44
1982 55
1983 67
1984 65
1985 97
1986 79
1987 89
1988 95
1989 107
1990 141
1991 155
1992 178
1993 245
1994 276
1995 340
1996 397
1997 444
1998 502
1999 523
2000 595
2001 623
2002 701
2003 776
2004 891
2005 970
2006 1161
2007 1290
2008 1421
2009 1731
2010 1904
2011 2111
2012 2397
2013 2689
2014 3330
2015 3699
2016 4141
2017 4508
2018 4792
2019 5231
2020 5816
2021 6305
2022 6264
2023 5945
2024 2889

Text availability

Article attribute

Article type

Publication date

Search Results

67,160 results

Results by year

Filters applied: . Clear all
Page 1
Is Hospital Nurse Staffing Legislation in the Public's Interest?: An Observational Study in New York State.
Lasater KB, Aiken LH, Sloane DM, French R, Anusiewicz CV, Martin B, Reneau K, Alexander M, McHugh MD. Lasater KB, et al. Med Care. 2021 May 1;59(5):444-450. doi: 10.1097/MLR.0000000000001519. Med Care. 2021. PMID: 33655903 Free PMC article.
After adjusting for potential confounders each additional patient per nurse, for surgical and medical patients, respectively, was associated with higher odds of in-hospital mortality [odds ratio (OR)=1.13, P=0.0262; OR=1.13, P=0.0019], longer lengths of stay (incidence rat …
After adjusting for potential confounders each additional patient per nurse, for surgical and medical patients, respectively, was associated …
Pharmacoeconomics.
Sule NS, Nerurkar RP, Kamath SA. Sule NS, et al. J Assoc Physicians India. 2002 Aug;50:1057-62. J Assoc Physicians India. 2002. PMID: 12421032 Review.
Then one compares these costs and benefits by calculating a cost: benefit ratio for each regimen. Four types of economic analyses are commonly used for this purpose. ...Finally study designs generally used for generating data for a pharmacoeconomic analysis are mentioned, …
Then one compares these costs and benefits by calculating a cost: benefit ratio for each regimen. Four types of economic analyses are …
Financial ratio analysis.
Choate GM. Choate GM. Hosp Prog. 1974 Jan;55(1):49-57 passim. Hosp Prog. 1974. PMID: 4809821 No abstract available.
Is individualized medicine more cost-effective? A systematic review.
Hatz MH, Schremser K, Rogowski WH. Hatz MH, et al. Pharmacoeconomics. 2014 May;32(5):443-55. doi: 10.1007/s40273-014-0143-0. Pharmacoeconomics. 2014. PMID: 24574059 Review.
Many studies reported more than one strategy of IM with highly varying cost-effectiveness ratios. Generally, results differed according to test type, and tests for disease prognosis or screening appeared to be more favorable than tests to stratify patients by response or b …
Many studies reported more than one strategy of IM with highly varying cost-effectiveness ratios. Generally, results differed accordi …
Common methodological flaws in economic evaluations.
Drummond M, Sculpher M. Drummond M, et al. Med Care. 2005 Jul;43(7 Suppl):5-14. doi: 10.1097/01.mlr.0000170001.10393.b7. Med Care. 2005. PMID: 16056003 Review.
The main flaws discussed are: (i) omission of important costs or benefits; (ii) inappropriate selection of alternatives for comparison; (iii) problems in making indirect comparisons; (iv) inadequate representation of the effectiveness data; (v) inappropriate extrapolation beyond …
The main flaws discussed are: (i) omission of important costs or benefits; (ii) inappropriate selection of alternatives for comparison; (iii …
Variations in payment patterns for surgical care in the centers for Medicare and Medicaid Services.
Bergman J, Laviana AA, Kwan L, Lerman SE, Aronson WJ, Bennett CJ, Hu JJ. Bergman J, et al. Surgery. 2017 Feb;161(2):312-319. doi: 10.1016/j.surg.2015.12.028. Epub 2016 Feb 26. Surgery. 2017. PMID: 26922367 Review.
We included Medicare B participants in the fee-for-service program. We calculated for each provider the ratio of number of services provided to individual beneficiaries, and the ratio of total submitted charges to total Medicare payments. ...Charges were consistentl …
We included Medicare B participants in the fee-for-service program. We calculated for each provider the ratio of number of services p …
Resource Misallocation and Energy-Related Pollution.
He LY, Qi XF. He LY, et al. Int J Environ Res Public Health. 2021 May 13;18(10):5158. doi: 10.3390/ijerph18105158. Int J Environ Res Public Health. 2021. PMID: 34068005 Free PMC article.
Further investigation, resource misallocation is accompanied by an increase in total energy input, a decrease in the labor-to-energy ratio and the capital-to-energy ratio, and a loss of energy efficiency, which in turn affects the environmental performance of …
Further investigation, resource misallocation is accompanied by an increase in total energy input, a decrease in the labor-to-energy rati …
Financial-ratio analysis and medical school management.
Eastaugh SR. Eastaugh SR. J Med Educ. 1980 Dec;55(12):983-92. doi: 10.1097/00001888-198012000-00001. J Med Educ. 1980. PMID: 7452714
Medical schools have an uneven ability to compensate for declining federal capitation and research grants. Financial-ratio analysis and cluster analysis are utilized to suggest four adaptive responses to future financial pressures. ...
Medical schools have an uneven ability to compensate for declining federal capitation and research grants. Financial-ratio analysis a …
The Price of Substitute Technologies.
Santos AS, Guerra-Junior AA, Noronha KVMS, Andrade MV, Ruas CM. Santos AS, et al. Value Health Reg Issues. 2019 Dec;20:154-158. doi: 10.1016/j.vhri.2019.08.474. Epub 2019 Sep 25. Value Health Reg Issues. 2019. PMID: 31561148 Free article.
RESULTS: There is no reason for us to believe that the oligopolistic pharmaceutical market is currently charging prices at the cost of production. That way, the cost-effectiveness ratio of the incumbent technology, when lower than kappa, is shown through a deductive proces …
RESULTS: There is no reason for us to believe that the oligopolistic pharmaceutical market is currently charging prices at the cost of produ …
67,160 results
You have reached the last available page of results. Please see the User Guide for more information.